Daniel Reker1,2, Petra Schneider1,3, Gisbert Schneider1, J B Brown4. 1. Computer-Assisted Drug Design, Institute of Pharmaceutical Sciences, Department of Chemistry & Applied Biosciences, Swiss Federal Institute of Technology (ETH Zurich), Vladimir-Prelog-Weg 1-5/10, 8093 Zurich, Switzerland. 2. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main St, Cambridge, MA 02139, USA. 3. inSili.com GmbH, Segantinisteig 3, 8049 Zurich, Switzerland. 4. Kyoto University Graduate School of Medicine, Center for Medical Education, Life Science Informatics Research Unit, Kyoto 606-8501, Japan.
Abstract
AIM: Computational chemogenomics models the compound-protein interaction space, typically for drug discovery, where existing methods predominantly either incorporate increasing numbers of bioactivity samples or focus on specific subfamilies of proteins and ligands. As an alternative to modeling entire large datasets at once, active learning adaptively incorporates a minimum of informative examples for modeling, yielding compact but high quality models. Results/methodology: We assessed active learning for protein/target family-wide chemogenomic modeling by replicate experiment. Results demonstrate that small yet highly predictive models can be extracted from only 10-25% of large bioactivity datasets, irrespective of molecule descriptors used. CONCLUSION: Chemogenomic active learning identifies small subsets of ligand-target interactions in a large screening database that lead to knowledge discovery and highly predictive models.
AIM: Computational chemogenomics models the compound-protein interaction space, typically for drug discovery, where existing methods predominantly either incorporate increasing numbers of bioactivity samples or focus on specific subfamilies of proteins and ligands. As an alternative to modeling entire large datasets at once, active learning adaptively incorporates a minimum of informative examples for modeling, yielding compact but high quality models. Results/methodology: We assessed active learning for protein/target family-wide chemogenomic modeling by replicate experiment. Results demonstrate that small yet highly predictive models can be extracted from only 10-25% of large bioactivity datasets, irrespective of molecule descriptors used. CONCLUSION: Chemogenomic active learning identifies small subsets of ligand-target interactions in a large screening database that lead to knowledge discovery and highly predictive models.
Keywords:
chemogenomics; computational chemistry and modeling; virtual screening
Authors: Kamel Mansouri; Agnes L Karmaus; Jeremy Fitzpatrick; Grace Patlewicz; Prachi Pradeep; Domenico Alberga; Nathalie Alepee; Timothy E H Allen; Dave Allen; Vinicius M Alves; Carolina H Andrade; Tyler R Auernhammer; Davide Ballabio; Shannon Bell; Emilio Benfenati; Sudin Bhattacharya; Joyce V Bastos; Stephen Boyd; J B Brown; Stephen J Capuzzi; Yaroslav Chushak; Heather Ciallella; Alex M Clark; Viviana Consonni; Pankaj R Daga; Sean Ekins; Sherif Farag; Maxim Fedorov; Denis Fourches; Domenico Gadaleta; Feng Gao; Jeffery M Gearhart; Garett Goh; Jonathan M Goodman; Francesca Grisoni; Christopher M Grulke; Thomas Hartung; Matthew Hirn; Pavel Karpov; Alexandru Korotcov; Giovanna J Lavado; Michael Lawless; Xinhao Li; Thomas Luechtefeld; Filippo Lunghini; Giuseppe F Mangiatordi; Gilles Marcou; Dan Marsh; Todd Martin; Andrea Mauri; Eugene N Muratov; Glenn J Myatt; Dac-Trung Nguyen; Orazio Nicolotti; Reine Note; Paritosh Pande; Amanda K Parks; Tyler Peryea; Ahsan H Polash; Robert Rallo; Alessandra Roncaglioni; Craig Rowlands; Patricia Ruiz; Daniel P Russo; Ahmed Sayed; Risa Sayre; Timothy Sheils; Charles Siegel; Arthur C Silva; Anton Simeonov; Sergey Sosnin; Noel Southall; Judy Strickland; Yun Tang; Brian Teppen; Igor V Tetko; Dennis Thomas; Valery Tkachenko; Roberto Todeschini; Cosimo Toma; Ignacio Tripodi; Daniela Trisciuzzi; Alexander Tropsha; Alexandre Varnek; Kristijan Vukovic; Zhongyu Wang; Liguo Wang; Katrina M Waters; Andrew J Wedlake; Sanjeeva J Wijeyesakere; Dan Wilson; Zijun Xiao; Hongbin Yang; Gergely Zahoranszky-Kohalmi; Alexey V Zakharov; Fagen F Zhang; Zhen Zhang; Tongan Zhao; Hao Zhu; Kimberley M Zorn; Warren Casey; Nicole C Kleinstreuer Journal: Environ Health Perspect Date: 2021-04-30 Impact factor: 9.031
Authors: Petra Schneider; W Patrick Walters; Alleyn T Plowright; Norman Sieroka; Jennifer Listgarten; Robert A Goodnow; Jasmin Fisher; Johanna M Jansen; José S Duca; Thomas S Rush; Matthias Zentgraf; John Edward Hill; Elizabeth Krutoholow; Matthias Kohler; Jeff Blaney; Kimito Funatsu; Chris Luebkemann; Gisbert Schneider Journal: Nat Rev Drug Discov Date: 2019-12-04 Impact factor: 84.694
Authors: AkshatKumar Nigam; Robert Pollice; Matthew F D Hurley; Riley J Hickman; Matteo Aldeghi; Naruki Yoshikawa; Seyone Chithrananda; Vincent A Voelz; Alán Aspuru-Guzik Journal: Expert Opin Drug Discov Date: 2021-06-15 Impact factor: 7.050